Search

Elli Peselev

Examiner (ID: 6644)

Most Active Art Unit
1623
Art Unit(s)
1803, 1673, 1211, 2899, 1623, 1621, 1203, 1802
Total Applications
2819
Issued Applications
1827
Pending Applications
143
Abandoned Applications
853

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10082528 [patent_doc_number] => 09119858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-01 [patent_title] => 'Compositions and methods for treating or preventing anthracycline induced cardiotoxicity' [patent_app_type] => utility [patent_app_number] => 13/971281 [patent_app_country] => US [patent_app_date] => 2013-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 11 [patent_no_of_words] => 7511 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13971281 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/971281
Compositions and methods for treating or preventing anthracycline induced cardiotoxicity Aug 19, 2013 Issued
13/985486 NEW ANTIFUNGAL COMPOSITIONS Aug 13, 2013 Abandoned
Array ( [id] => 9175087 [patent_doc_number] => 20130317072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'Method To Enhance Delivery Of Glutathione And ATP Levels In Cells' [patent_app_type] => utility [patent_app_number] => 13/958530 [patent_app_country] => US [patent_app_date] => 2013-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3777 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13958530 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/958530
Method to enhance delivery of glutathione and ATP levels in cells Aug 1, 2013 Issued
Array ( [id] => 10191826 [patent_doc_number] => 09220719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad' [patent_app_type] => utility [patent_app_number] => 13/944904 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6035 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944904 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/944904
Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad Jul 17, 2013 Issued
Array ( [id] => 9295536 [patent_doc_number] => 20140039170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'COMPOSITION FOR TOPICAL SKIN APPLICATION CONTAINING GINSENOSIDE F2 DERIVED FROM HYDROPONIC GINSENG' [patent_app_type] => utility [patent_app_number] => 13/935801 [patent_app_country] => US [patent_app_date] => 2013-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14036 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935801 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/935801
COMPOSITION FOR TOPICAL SKIN APPLICATION CONTAINING GINSENOSIDE F2 DERIVED FROM HYDROPONIC GINSENG Jul 4, 2013 Abandoned
Array ( [id] => 9546768 [patent_doc_number] => 20140171416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'CEPHALOTAXUS ESTERS, METHODS OF SYNTHESIS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/920899 [patent_app_country] => US [patent_app_date] => 2013-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 53023 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13920899 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/920899
Cephalotaxus esters, methods of synthesis, and uses thereof Jun 17, 2013 Issued
13/906498 COMPOSITIONS COMPRISING NINGNANMYCIN AND USES THEREFOR May 30, 2013 Abandoned
Array ( [id] => 9957379 [patent_doc_number] => 09005578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-14 [patent_title] => 'Compounds and compositions for the detection and treatment of Alzheimer\'s disease and related disorders' [patent_app_type] => utility [patent_app_number] => 13/903362 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 23073 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903362 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/903362
Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders May 27, 2013 Issued
Array ( [id] => 9983625 [patent_doc_number] => 09029334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Pharmaceutical composition for prevention or treatment of bone diseases comprising spinasterol glucoside derivative' [patent_app_type] => utility [patent_app_number] => 13/893240 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5419 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893240 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/893240
Pharmaceutical composition for prevention or treatment of bone diseases comprising spinasterol glucoside derivative May 12, 2013 Issued
Array ( [id] => 9082162 [patent_doc_number] => 20130267692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-10 [patent_title] => 'PROCEDURE FOR THE PURIFICATION OF TIACUMICIN B' [patent_app_type] => utility [patent_app_number] => 13/855969 [patent_app_country] => US [patent_app_date] => 2013-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2058 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13855969 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/855969
Procedure for the purification of tiacumicin B Apr 2, 2013 Issued
Array ( [id] => 8976102 [patent_doc_number] => 20130209532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-15 [patent_title] => 'POLYSACCHARIDE GEL FORMULATION HAVING INCREASED LONGEVITY' [patent_app_type] => utility [patent_app_number] => 13/851861 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6196 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13851861 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/851861
Polysaccharide gel formulation having increased longevity Mar 26, 2013 Issued
Array ( [id] => 9232825 [patent_doc_number] => 08598129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'Topical application of ivermectin for the treatment of dermatological conditions/afflictions' [patent_app_type] => utility [patent_app_number] => 13/851816 [patent_app_country] => US [patent_app_date] => 2013-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4514 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13851816 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/851816
Topical application of ivermectin for the treatment of dermatological conditions/afflictions Mar 26, 2013 Issued
Array ( [id] => 10892915 [patent_doc_number] => 08916527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Antibiotic macrocycle compounds and methods of manufacture and use thereof' [patent_app_type] => utility [patent_app_number] => 13/832869 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9761 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13832869 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/832869
Antibiotic macrocycle compounds and methods of manufacture and use thereof Mar 14, 2013 Issued
Array ( [id] => 10000434 [patent_doc_number] => 09044508 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Concentrated aqueous azalide formulations' [patent_app_type] => utility [patent_app_number] => 13/843267 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8054 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13843267 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/843267
Concentrated aqueous azalide formulations Mar 14, 2013 Issued
Array ( [id] => 8951434 [patent_doc_number] => 20130197215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'Chlorination of Carbohydrates and Carbohydrate Derivatives' [patent_app_type] => utility [patent_app_number] => 13/826851 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6614 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13826851 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/826851
Chlorination of carbohydrates and carbohydrate derivatives Mar 13, 2013 Issued
Array ( [id] => 9094906 [patent_doc_number] => 20130274217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'Controlled Release Formulations for the Delivery of HIF-1 Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/797506 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23118 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13797506 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/797506
Controlled release formulations for the delivery of HIF-1 inhibitors Mar 11, 2013 Issued
Array ( [id] => 9281566 [patent_doc_number] => 20140031534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/790140 [patent_app_country] => US [patent_app_date] => 2013-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23115 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13790140 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/790140
COMPOUNDS Mar 7, 2013 Abandoned
Array ( [id] => 9937620 [patent_doc_number] => 08987430 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Efficient and scalable process for the manufacture of fondaparinux sodium' [patent_app_type] => utility [patent_app_number] => 13/791178 [patent_app_country] => US [patent_app_date] => 2013-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17991 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13791178 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/791178
Efficient and scalable process for the manufacture of fondaparinux sodium Mar 7, 2013 Issued
Array ( [id] => 9245349 [patent_doc_number] => 08609630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Vitamin B12 compositions' [patent_app_type] => utility [patent_app_number] => 13/759913 [patent_app_country] => US [patent_app_date] => 2013-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8412 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13759913 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/759913
Vitamin B12 compositions Feb 4, 2013 Issued
Array ( [id] => 9603512 [patent_doc_number] => 20140200194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-17 [patent_title] => 'USE OF URARIA IN PROMOTING OSTEOGENESIS OR PROVIDING NEUROPROTECTION' [patent_app_type] => utility [patent_app_number] => 13/742717 [patent_app_country] => US [patent_app_date] => 2013-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9628 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13742717 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/742717
Use of uraria in promoting osteogenesis or providing neuroprotection Jan 15, 2013 Issued
Menu